MENU
+Compare
HAE
Stock ticker: NYSE
AS OF
May 23 closing price
Price
$66.06
Change
-$0.10 (-0.15%)
Capitalization
4.33B

HAE Haemonetics Corp Forecast, Technical & Fundamental Analysis

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more

HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HAE with price predictions
May 23, 2025

HAE's Stochastic Oscillator slumps oversold zone

The Stochastic Oscillator for HAE moved into oversold territory on May 23, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

HAE moved above its 50-day moving average on May 06, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HAE crossed bullishly above the 50-day moving average on May 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 209 cases where HAE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HAE moved out of overbought territory on May 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 22, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HAE as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HAE turned negative on May 22, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HAE broke above its upper Bollinger Band on May 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HAE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.564) is normal, around the industry mean (24.191). P/E Ratio (34.467) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (1.624) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.428) is also within normal values, averaging (42.393).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HAE is expected to report earnings to fall 18.55% to $1.01 per share on August 12

Haemonetics Corp HAE Stock Earnings Reports
Q2'25
Est.
$1.01
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.01
The last earnings report on May 08 showed earnings per share of $1.24, beating the estimate of $1.22. With 356.41K shares outstanding, the current market capitalization sits at 4.33B.
A.I. Advisor
published General Information

General Information

a manufacturer of blood processing systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
125 Summer Street
Phone
+1 781 848-7100
Employees
3034
Web
https://www.haemonetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PXI41.120.39
+0.96%
Invesco Dorsey Wright Energy MomentumETF
TDSC23.73-0.02
-0.09%
Cabana Target Drawdown 10 ETF
IYJ136.18-0.75
-0.55%
iShares US Industrials ETF
XTR26.81-0.18
-0.68%
Global X S&P 500® Tail Risk ETF
TECB52.94-0.51
-0.95%
iShares US Tech Breakthrough Mltsctr ETF

HAE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with ATR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then ATR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-0.15%
ATR - HAE
41%
Loosely correlated
-0.45%
CNMD - HAE
39%
Loosely correlated
-3.50%
GH - HAE
38%
Loosely correlated
+2.45%
LH - HAE
37%
Loosely correlated
+0.26%
HOLX - HAE
36%
Loosely correlated
-0.37%
More